4//SEC Filing
Wong Alvin F 4
Accession 0001437749-23-003388
CIK 0001401667other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:00 PM ET
Size
7.1 KB
Accession
0001437749-23-003388
Insider Transaction Report
Form 4
Wong Alvin F
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-02-10+58,601→ 113,154 total - Award
Stock Option (Right to Buy)
2023-02-10+81,399→ 81,399 totalExercise: $4.39Exp: 2033-02-09→ Common Stock (81,399 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Grantee's continued service with the Company through the applicable vesting date.
- [F2]Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Optionee's continued service with the Company through the applicable vesting date.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001868855
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:00 PM ET
- Size
- 7.1 KB